DCDC Health Services Pvt Ltd — a major operator of dialysis clinics in India under its brand DCDC Kidney Care — has raised ₹82 crore (nearly $10 million) in funding from British International Investment (BII), the United Kingdom’s government‑owned development finance institution.
The investment comes in the form of debt capital and is aimed at scaling up the company’s network of dialysis facilities over the next three years. Specifically, DCDC plans to install more than 900 dialysis machines and expand its presence to over 100 centres nationwide, particularly focusing on underserved regions in South India, including Karnataka and Telangana.
Most of the patients who will benefit from this expansion are low‑income individuals suffering from end‑stage renal disease (ESRD) — a condition requiring regular dialysis to sustain life. With this new funding, the company expects to serve over 15,000 unique patients and generate around 1,000 new direct jobs as it grows its footprint.
DCDC currently operates over 190 clinics across India, including public‑private partnership (PPP) units, standalone clinics, and units inside private hospitals. The funding from BII will support both growth in existing markets and establishment of new centres, expanding access to life‑saving haemodialysis and related renal care services for economically vulnerable populations.
About British International Investment:
British International Investment is a UK government‑owned development finance institution focused on investing in emerging markets across Asia, Africa, and other regions to promote sustainable economic development. It provides long‑term capital (both equity and debt) to businesses that can drive growth, job creation, and improved access to essential services like healthcare.